Skip to content

Aquestive Therapeutics Inc

AQST

Latest QuantConomy context for AQST: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile

Aquestive Therapeutics Inc

QuantConomy has a structured record for AQST. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
AQST
Name
Aquestive Therapeutics Inc
Coverage
3 market/data records
Sources
fmp alpaca alphavantage sec nasdaq
Latest signal rows

Recent signals for AQST

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
eps change
very bullish
76
May 13, 12:00 AM AQST (Q1 2026, diluted eps): EPS grew 91.0% ($-0.78 → $-0.07). [sequential period basis, very bullish signal]
revenue change
very bearish
76
May 13, 12:00 AM AQST (Q1 2026, revenue): declined 67.6% ($44.55M → $14.45M). [sequential period basis, very bearish signal]
operating income change
very bullish
76
May 13, 12:00 AM AQST (Q1 2026, operating income): grew 94.1% (-$71.05M → -$4.20M). [sequential period basis, very bullish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.

Market coverage

Market Exchange Source Asset record
AQST NASDAQ fmp Aquestive Therapeutics, Inc.
AQST NASDAQ alpaca Aquestive Therapeutics, Inc. Common Stock
AQST NASDAQ alphavantage Aquestive Therapeutics Inc

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
2
Rows
20
Date Insider Role Type Shares Price Value Filing
Jun 23, 2026 Krop Julie Director exercise 25,000 $0.71 $17,830 4 on EDGAR
Jun 15, 2026 Barber Daniel President and CEO sale 25,000 $4.16 $104,010 4 on EDGAR
Jun 10, 2026 BROWN GREGORY B Director grant 50,500 4 on EDGAR
Jun 10, 2026 Taglietti Marco Director grant 50,500 4 on EDGAR
Jun 10, 2026 MORRIS TIMOTHY E Director grant 50,500 4 on EDGAR
Jun 10, 2026 Krop Julie Director grant 50,500 4 on EDGAR
Jun 10, 2026 Jenkins Abigail L. Director grant 50,500 4 on EDGAR
Jun 10, 2026 Cochran John Director grant 50,500 4 on EDGAR
Jun 8, 2026 Korczynski Sherry Chief Commercial Officer other 2,714 $0.00 $0 4 on EDGAR
May 18, 2026 Zalewski Thomas A. Chief Legal Officer grant 100,000 $0.00 $0 4 on EDGAR
May 15, 2026 Barber Daniel President and CEO sale 8,257 $4.29 $35,413 4 on EDGAR
May 15, 2026 Cioffi Melina SVP, Regulatory Affairs other 1,667 $4.17 $6,951 4 on EDGAR
May 7, 2026 BRAENDER LORI J Corporate Secretary other 135,690 $4.23 $573,969 4 on EDGAR
May 5, 2026 Boyd Peter E. Chief People Officer other 56,778 $4.18 $237,332 4 on EDGAR
May 5, 2026 Jung Cassie Chief Operating Officer other 72,734 $4.18 $304,028 4 on EDGAR
May 5, 2026 Barber Daniel President and CEO other 335,922 $4.18 $1,404,154 4 on EDGAR
May 5, 2026 BRAENDER LORI J Corporate Secretary other 76,147 $4.18 $318,294 4 on EDGAR
May 5, 2026 TOTH A ERNEST JR Chief Financial Officer other 92,652 $4.18 $387,285 4 on EDGAR
Zalewski Thomas A. Chief Legal Officer 3 on EDGAR
Mar 9, 2026 Barber Daniel President and CEO grant 262,000 $0.00 $0 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query AQST context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access